I am preparing MDS Peridontology notes. I already have the textbook answer. Do NOT write a complete answer. Instead, provide only Landmark, highly cited, guideline-changing or examination-relevant research articles related to CRITICAL ANALYSIS OF SPECIAL CONSIDERATIONS IN TREATMENT OF AGGRESSIVE FORMS OF PERIODONTAL DISEASE.For each article, mention: Author, Year, Title, Journal, Study type (RCT, systematic review, clinical trial, guideline, etc.), Key contribution, why it is important for postgraduate exam. Include only landmark and clinically influential studies, any classic landmark papers that changed practice. For every paper provide full citation, importance rating (⭐ to ⭐⭐⭐⭐⭐), and key contributions
Reading File
Finding Sources
Searching PubMed
aggressive periodontitis treatment systemic antibiotics
Searching the Web
landmark research articles aggressive periodontitis treatment special considerations postgraduate periodontics
Searching PubMed
aggressive periodontitis genetics familial aggregation Michalowicz Kornman
Searching PubMed
Aggregatibacter actinomycetemcomitans localized aggressive periodontitis Slots Hafajee
Searching PubMed
aggressive periodontitis 2018 classification staging grading
Searching PubMed
localized aggressive periodontitis neutrophil defect Cianciola Lavine
Searching PubMed
aggressive periodontitis implants long-term prognosis Mengel
Searching PubMed
Guerrero amoxicillin metronidazole generalized aggressive periodontitis RCT 2005
Searching PubMed
Guerrero amoxicillin metronidazole non-surgical aggressive periodontitis placebo-controlled
Searching PubMed
Haubek JP2 clone Aggregatibacter adolescent aggressive periodontitis Morocco Lancet
I now have comprehensive data. Let me compile the definitive landmark article list for the postgraduate exams.
Landmark Research Articles: Critical Analysis of Special Considerations in Treatment of Aggressive Periodontal Disease
Curated for MDS Periodontology Postgraduate Examinations
SECTION 1 - CLASSIFICATION & NOMENCLATURE (Foundation Articles)
1. Lang NP et al. / 1999 (International Workshop for Classification)
Full Citation: Lang NP, Bartold PM, Cullinan M, et al. Consensus report: Aggressive periodontitis. Annals of Periodontology. 1999;4(1):53.
| Field | Detail |
|---|---|
| Study Type | Consensus/Workshop Report |
| Importance | ⭐⭐⭐⭐⭐ |
Key Contribution: Formally established "Aggressive Periodontitis" as a distinct diagnostic entity, replacing "Early-Onset Periodontitis," "Juvenile Periodontitis," and "Rapidly Progressive Periodontitis." Defined primary (rapid attachment loss, familial aggregation) and secondary (phagocyte abnormalities, macrophage hyperresponsiveness, self-limiting) features of both localized (LAgP) and generalized (GAgP) forms.
Why it matters for PG exams: This is THE classification article. Every question on distinguishing LAgP vs GAgP, diagnostic criteria, and the 1999 AAP workshop references this paper. Must-know definitions.
2. Tonetti MS, Greenwell H, Kornman KS / 2018
Full Citation: Tonetti MS, Greenwell H, Kornman KS. Staging and grading of periodontitis: Framework and proposal of a new classification and case definition. Journal of Clinical Periodontology. 2018;45 Suppl 20:S149-S161. PMID: 29926495
Also published in: Journal of Periodontology. 2018;89 Suppl 1:S159-S172. PMID: 29926952
| Field | Detail |
|---|---|
| Study Type | Consensus Review / Workshop Report (2017 World Workshop) |
| Importance | ⭐⭐⭐⭐⭐ |
Key Contribution: Abolished the term "Aggressive Periodontitis" as a separate category. Replaced the chronic/aggressive binary with a Staging (I-IV) and Grading (A-B-C) framework. Aggressive periodontitis now maps to Grade C periodontitis (rapid progression, early onset, risk factor profile). This is one of the most disruptive paradigm shifts in modern periodontology.
Why it matters for PG exams: Examiners actively test whether candidates understand the 2018 reclassification. Can be asked as "What happened to aggressive periodontitis in the 2018 classification?" or "How does Grade C correspond to aggressive periodontitis?" Must be able to justify both old (1999) and new (2018) frameworks critically.
3. Papapanou PN, Sanz M, Buduneli N et al. / 2018
Full Citation: Papapanou PN, Sanz M, Buduneli N, et al. Periodontitis: Consensus report of workgroup 2 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. Journal of Clinical Periodontology. 2018;45 Suppl 20:S162-S170. PMID: 29926490
| Field | Detail |
|---|---|
| Study Type | Consensus Statement |
| Importance | ⭐⭐⭐⭐⭐ |
Key Contribution: Provided the evidence base and scientific rationale for why the aggressive/chronic distinction lacked biological justification and could not be reliably separated clinically. Justified transition to the stage/grade framework. Introduced Grade C modifiers including "molar-incisor pattern."
Why it matters for PG exams: Paired with Tonetti 2018 - together these two papers are the backbone of all modern classification questions. Explains the "why" behind the 2018 reclassification.
SECTION 2 - MICROBIOLOGY (Etiology-Based Special Considerations)
4. Slots J, Genco RJ / 1984
Full Citation: Slots J, Genco RJ. Black-pigmented Bacteroides species, Capnocytophaga species, and Actinobacillus actinomycetemcomitans in human periodontal disease: virulence factors in colonization, survival, and tissue destruction. Reviews of Infectious Diseases. 1984;6(1):107-112. PMID: 6374577
| Field | Detail |
|---|---|
| Study Type | Review/Classic Paper |
| Importance | ⭐⭐⭐⭐⭐ |
Key Contribution: Established Actinobacillus actinomycetemcomitans (now Aggregatibacter actinomycetemcomitans) as the primary etiologic agent in localized aggressive periodontitis. Described leukotoxin and collagenase as key virulence factors. This was foundational for antibiotic selection in treatment.
Why it matters for PG exams: Basis for the entire microbiological rationale behind treating LAgP with tetracyclines - examined frequently. Also tests knowledge of virulence factors (leukotoxin, LPS, collagenase, epitheliotoxin).
5. Haubek D, Ennibi OK, Poulsen K et al. / 2008
Full Citation: Haubek D, Ennibi OK, Poulsen K, Vaeth M, Poulsen S, Kilian M. Risk of aggressive periodontitis in adolescent carriers of the JP2 clone of Aggregatibacter (Actinobacillus) actinomycetemcomitans in Morocco: a prospective longitudinal cohort study. Lancet. 2008;371(9608):237-242. PMID: 18207019
| Field | Detail |
|---|---|
| Study Type | Prospective Longitudinal Cohort Study |
| Importance | ⭐⭐⭐⭐⭐ |
Key Contribution: Landmark Lancet paper demonstrating that the highly leukotoxic JP2 clone of A. actinomycetemcomitans dramatically increases the risk of aggressive periodontitis in adolescents (18x relative risk). Showed that JP2 clone carriers who converted had 12-fold higher risk of alveolar bone loss. Established this clone as a true causative agent - not just an association.
Why it matters for PG exams: The only prospective study establishing causality for a specific periodontal pathogen. Published in Lancet, giving it extraordinary weight. Tested in questions on the JP2 clone, leukotoxin, African/Moroccan populations, and risk assessment.
6. Fine DH, Markowitz K, Furgang D et al. / 2007
Full Citation: Fine DH, Markowitz K, Furgang D, Fairlie K, Ferrandiz J, Nasri C. Aggregatibacter actinomycetemcomitans and its relationship to initiation of localized aggressive periodontitis: longitudinal cohort study of initially healthy adolescents. Journal of Clinical Microbiology. 2007;45(12):3859-3869.
| Field | Detail |
|---|---|
| Study Type | Longitudinal Cohort Study |
| Importance | ⭐⭐⭐⭐ |
Key Contribution: Demonstrated that colonization with A. actinomycetemcomitans in initially healthy adolescents predicted subsequent development of bone loss, providing longitudinal evidence for its initiating role in LAgP. Supported early antibiotic intervention as part of a preventive-therapeutic strategy.
Why it matters for PG exams: Supports clinical rationale for treating the organism before irreversible damage occurs - answers questions on "when to start antibiotics" and microbiological monitoring.
SECTION 3 - HOST RESPONSE / IMMUNOLOGY (Special Host Considerations)
7. Van Dyke TE, Horoszewicz HU, Cianciola LJ, Genco RJ / 1980
Full Citation: Van Dyke TE, Horoszewicz HU, Cianciola LJ, Genco RJ. Neutrophil chemotaxis dysfunction in human periodontitis. Infection and Immunity. 1980;27(1):124-132. PMID: 6987164
| Field | Detail |
|---|---|
| Study Type | Classic Experimental Study |
| Importance | ⭐⭐⭐⭐⭐ |
Key Contribution: Landmark paper demonstrating intrinsic neutrophil chemotaxis defects in localized aggressive periodontitis patients. Showed that the defect was cell-intrinsic (not serum-mediated), persisted after successful treatment, and occurred in unaffected family members - indicating a genetic predisposition. Established host immune dysfunction as a primary special consideration.
Why it matters for PG exams: THE paper that explains why LAgP patients are susceptible despite minimal local factors. Direct basis for the "host modulation" arm of treatment. Questions on neutrophil defects, PMN dysfunction, and familial patterns all reference this work.
8. Shapira L, Soskolne WA, Sela MN, Offenbacher S, Barak V / 1994
Full Citation: Shapira L, Soskolne WA, Sela MN, Offenbacher S, Barak V. The secretion of PGE2, IL-1β, IL-6, and TNF-α by adherent mononuclear cells from early onset periodontitis patients. Journal of Periodontology. 1994;65(2):139-146.
| Field | Detail |
|---|---|
| Study Type | Experimental Clinical Study |
| Importance | ⭐⭐⭐⭐ |
Key Contribution: Showed that monocytes from aggressive periodontitis patients hyper-secrete PGE2, IL-1β, IL-6, and TNF-α in response to LPS - the "hyper-inflammatory monocyte phenotype." This was the immunological evidence base for the secondary feature of aggressive periodontitis listed in the 1999 classification.
Why it matters for PG exams: Explains the immune-inflammatory amplification in aggressive forms and justifies host-modulation therapy. Frequently examined in the context of cytokine profiles and monocyte hyperresponsiveness.
SECTION 4 - ANTIBIOTIC THERAPY (Core Special Consideration)
9. Slots J, Rosling BG / 1983
Full Citation: Slots J, Rosling BG. Suppression of the periodontopathic microflora in localized juvenile periodontitis by systemic tetracycline. Journal of Clinical Periodontology. 1983;10(5):465-486. PMID: 6358334
| Field | Detail |
|---|---|
| Study Type | Classic Clinical Study |
| Importance | ⭐⭐⭐⭐⭐ |
Key Contribution: First demonstrated that systemic tetracycline (as an adjunct to SRP) effectively suppressed A. actinomycetemcomitans and significantly improved clinical outcomes in localized juvenile periodontitis (now LAgP). This paper established the gold standard of "SRP + systemic tetracycline" for LAgP treatment, used for decades.
Why it matters for PG exams: Classic paper directly answering "Why is tetracycline the antibiotic of choice in LAgP?" Also introduces the concept that SRP alone is insufficient for aggressive periodontitis - antibiotics are necessary to eliminate tissue-invading bacteria.
10. Guerrero A, Griffiths GS, Nibali L et al. / 2005
Full Citation: Guerrero A, Griffiths GS, Nibali L, Suvan J, Moles DR, Laurell L, Tonetti MS. Adjunctive benefits of systemic amoxicillin and metronidazole in non-surgical treatment of generalized aggressive periodontitis: a randomized placebo-controlled clinical trial. Journal of Clinical Periodontology. 2005;32(10):1096-1107. PMID: 16174275
| Field | Detail |
|---|---|
| Study Type | Randomized Placebo-Controlled Clinical Trial (RCT) |
| Importance | ⭐⭐⭐⭐⭐ |
Key Contribution: First and most highly cited RCT showing that adjunctive amoxicillin (500mg TID) + metronidazole (400mg TID) for 7 days combined with non-surgical SRP produced significantly greater CAL gains, PPD reductions, and BOP reductions at 6 months in GAgP compared to SRP + placebo. Established the amox+metro combination as the evidence-based antibiotic regimen for GAgP.
Why it matters for PG exams: This is the single most important RCT for antibiotic treatment of GAgP. Every question on "which antibiotic in generalized aggressive periodontitis" or "evidence for antibiotics in aggressive periodontitis" traces back here.
11. Herrera D, Sanz M, Jepsen S et al. / 2002
Full Citation: Herrera D, Sanz M, Jepsen S, Needleman I, Roldán S. A systematic review on the effect of systemic antimicrobials as an adjunct to scaling and root planing in periodontitis patients. Journal of Clinical Periodontology. 2002;29 Suppl 3:136-159. PMID: 12787214
| Field | Detail |
|---|---|
| Study Type | Systematic Review / Meta-Analysis |
| Importance | ⭐⭐⭐⭐⭐ |
Key Contribution: Comprehensive systematic review confirming that systemic antimicrobials as adjuncts to SRP produce statistically significant additional clinical benefits. Importantly found that aggressive periodontitis patients showed the greatest benefit from systemic antibiotics among all periodontitis types - larger effect size than chronic periodontitis.
Why it matters for PG exams: Provides level I evidence answering "Do antibiotics help in aggressive periodontitis?" Also examined for "which periodontitis type benefits most from systemic antibiotics?"
12. Sgolastra F, Petrucci A, Gatto R et al. / 2012
Full Citation: Sgolastra F, Petrucci A, Gatto R, Monaco A. Effectiveness of systemic amoxicillin/metronidazole as an adjunctive therapy to full-mouth scaling and root planing in the treatment of aggressive periodontitis: a systematic review and meta-analysis. Journal of Periodontology. 2012;83(6):731-743. PMID: 22050545
| Field | Detail |
|---|---|
| Study Type | Systematic Review & Meta-Analysis |
| Importance | ⭐⭐⭐⭐⭐ |
Key Contribution: Meta-analysis specifically on amoxicillin + metronidazole as adjunct to full-mouth SRP in aggressive periodontitis. Quantified the additional benefit: approximately 0.5-1.0mm additional CAL gain and PPD reduction beyond SRP alone. Demonstrated consistent benefit across studies.
Why it matters for PG exams: The best quantitative evidence for amoxicillin+metronidazole in aggressive periodontitis. Used to frame evidence-based answers and compare magnitude of treatment benefit.
13. Rabelo CC, Feres M, Gonçalves C et al. / 2015
Full Citation: Rabelo CC, Feres M, Gonçalves C, Figueiredo LC, Faveri M, Tu YK, Needleman I. Systemic antibiotics in the treatment of aggressive periodontitis: a systematic review and Bayesian Network meta-analysis. Journal of Clinical Periodontology. 2015;42(7):647-657. PMID: 26087839
| Field | Detail |
|---|---|
| Study Type | Systematic Review + Bayesian Network Meta-Analysis |
| Importance | ⭐⭐⭐⭐ |
Key Contribution: Used Bayesian network meta-analysis to compare multiple antibiotic regimens in aggressive periodontitis. Found that the amoxicillin + metronidazole combination was superior to all other antibiotic regimens (tetracycline, azithromycin, amoxicillin alone, metronidazole alone). Ranked amox+metro as the most effective antibiotic combination.
Why it matters for PG exams: Answers the question "Which specific antibiotic combination is most effective in aggressive periodontitis?" with the highest level of evidence available. The "network meta-analysis" design is itself a high-yield concept.
14. Kaner D, Christan C, Dietrich T et al. / 2007
Full Citation: Kaner D, Christan C, Dietrich T, Bernimoulin JP, Kleber BM, Friedmann A. Timing affects the clinical outcome of adjunctive systemic antibiotic therapy for generalized aggressive periodontitis. Journal of Periodontology. 2007;78(7):1201-1208.
| Field | Detail |
|---|---|
| Study Type | Randomized Controlled Trial |
| Importance | ⭐⭐⭐⭐ |
Key Contribution: Compared amoxicillin + metronidazole given during active SRP vs. after completion of SRP in GAgP. Found that administering antibiotics during SRP (i.e., concurrent with mechanical debridement) produced significantly better clinical outcomes than post-SRP antibiotic use. Established the importance of TIMING in antibiotic prescription.
Why it matters for PG exams: Critical practical question - "When should antibiotics be given in relation to SRP?" This paper provides the direct evidence. Examinees should know: concurrent with SRP = better than delayed.
SECTION 5 - SURGICAL TREATMENT & REGENERATION (Special Considerations)
15. Mengel R, Schreiber D, Flores-de-Jacoby L / 2006
Full Citation: Mengel R, Schreiber D, Flores-de-Jacoby L. Bioabsorbable membrane and bioactive glass in the treatment of intrabony defects in patients with generalized aggressive periodontitis: results of a 5-year clinical and radiological study. Journal of Periodontology. 2006;77(10):1604-1611. PMID: 17032123
| Field | Detail |
|---|---|
| Study Type | Randomized Controlled Trial (5-year follow-up) |
| Importance | ⭐⭐⭐⭐ |
Key Contribution: Demonstrated that regenerative procedures (GTR with bioabsorbable membrane) in treated GAgP patients can produce clinically significant bone fill and CAL gains sustained over 5 years - comparable to outcomes in chronic periodontitis. Provided evidence that regeneration is viable in aggressive periodontitis provided the infection is controlled.
Why it matters for PG exams: Addresses the special consideration: "Can we do regenerative surgery in aggressive periodontitis patients?" Demonstrates favorable outcomes with proper disease control, challenging the perception that aggressive periodontitis precludes surgical intervention.
SECTION 6 - IMPLANTS IN AGGRESSIVE PERIODONTITIS (High-Yield Special Consideration)
16. Mengel R, Schröder T, Flores-de-Jacoby L / 2001
Full Citation: Mengel R, Schröder T, Flores-de-Jacoby L. Osseointegrated implants in patients treated for generalized chronic periodontitis and generalized aggressive periodontitis: 3- and 5-year results of a prospective long-term study. Journal of Periodontology. 2001;72(8):977-989. PMID: 11525449
| Field | Detail |
|---|---|
| Study Type | Prospective Cohort Study |
| Importance | ⭐⭐⭐⭐⭐ |
Key Contribution: First long-term study directly comparing implant survival in GAgP patients vs. chronic periodontitis patients. Demonstrated that implants in treated GAgP patients had significantly higher peri-implant bone loss, more peri-implant inflammation, and more complications compared to chronic periodontitis. Yet implant survival was still acceptable at 3-5 years with strict maintenance.
Why it matters for PG exams: The definitive study on implants in aggressive periodontitis, answering "Is implant placement contraindicated in aggressive periodontitis?" Answer: Not contraindicated but requires stricter maintenance, disease control, and monitoring. High-yield for oral rehabilitation discussions.
17. Mengel R, Flores-de-Jacoby L / 2005
Full Citation: Mengel R, Flores-de-Jacoby L. Implants in patients treated for generalized aggressive and chronic periodontitis: a 3-year prospective longitudinal study. Journal of Periodontology. 2005;76(4):534-543.
| Field | Detail |
|---|---|
| Study Type | Prospective Longitudinal Study |
| Importance | ⭐⭐⭐⭐ |
Key Contribution: Confirmed and extended the 2001 findings: implants in GAgP patients showed higher marginal bone loss, higher plaque, and bleeding scores than in chronic periodontitis patients, but osseointegration was maintained with controlled maintenance. Reinforced that history of aggressive periodontitis is a significant risk factor for peri-implantitis.
Why it matters for PG exams: Extended follow-up data for implants in aggressive periodontitis - shows that supportive periodontal therapy (SPT) is the critical special consideration for implant success in these patients.
SECTION 7 - GENETICS (Special Hereditary Considerations)
18. Michalowicz BS, Diehl SR, Gunsolley JC et al. / 2000
Full Citation: Michalowicz BS, Diehl SR, Gunsolley JC, Sparks BS, Brooks CN, Koertge TE, Koertge TE, Califano JV, Burmeister JA, Schenkein HA. Evidence of a substantial genetic basis for risk of adult periodontitis. Journal of Periodontology. 2000;71(11):1699-1707.
| Field | Detail |
|---|---|
| Study Type | Twin Study |
| Importance | ⭐⭐⭐⭐⭐ |
Key Contribution: Classic twin study demonstrating 50% heritability for periodontitis clinical parameters. Established that approximately half of the population susceptibility to periodontitis is genetically determined. Directly supports the familial aggregation feature of aggressive periodontitis and the rationale for family screening.
Why it matters for PG exams: Genetic component of aggressive periodontitis is a unique special consideration. This twin study is the most-cited evidence for heritability. Questions on "familial aggregation," "genetic risk," and "why screen family members" all trace here.
19. Hart TC, Kornman KS / 1997
Full Citation: Hart TC, Kornman KS. Genetic factors in the pathogenesis of periodontitis. Periodontology 2000. 1997;14:202-215.
| Field | Detail |
|---|---|
| Study Type | Review - Classic |
| Importance | ⭐⭐⭐⭐ |
Key Contribution: Comprehensively reviewed the genetic basis of periodontitis, emphasizing the role of specific gene polymorphisms (IL-1 gene cluster) in susceptibility. Established the framework for understanding why aggressive periodontitis shows familial aggregation and why certain individuals are at extreme risk despite similar microbial exposure. Proposed X-linked and autosomal dominant inheritance patterns for LAgP.
Why it matters for PG exams: Answers "What are the inheritance patterns in LAgP vs GAgP?" and provides the genetic basis for the clinical presentation. X-linked dominant pattern in LAgP (female:male ratio 3:1 in some studies) is a frequent examination question.
SECTION 8 - MAINTENANCE & LONG-TERM OUTCOMES (Special Long-Term Considerations)
20. Kamma JJ, Baehni PC / 2003
Full Citation: Kamma JJ, Baehni PC. Five-year maintenance follow-up of early-onset periodontitis patients. Journal of Clinical Periodontology. 2003;30(6):562-572.
| Field | Detail |
|---|---|
| Study Type | Prospective Cohort (5-year) |
| Importance | ⭐⭐⭐⭐ |
Key Contribution: 5-year maintenance study in early-onset (aggressive) periodontitis patients. Found that patients who completed thorough active treatment and entered 3-monthly maintenance had stable attachment levels comparable to those who had been well treated for chronic periodontitis. However, non-compliant patients showed rapid re-progression. Demonstrated that compliance with SPT is the critical factor for long-term stability.
Why it matters for PG exams: Directly answers "What is the prognosis of treated aggressive periodontitis?" and "What is the importance of SPT?" Supports the evidence that the disease can be controlled but not cured - the special consideration of lifelong maintenance.
21. Albandar JM / 2014
Full Citation: Albandar JM. Aggressive and acute periodontal diseases. Periodontology 2000. 2014;65(1):7-12.
| Field | Detail |
|---|---|
| Study Type | Review (Periodontology 2000 commissioned review) |
| Importance | ⭐⭐⭐⭐ |
Key Contribution: Comprehensive global review of aggressive periodontitis prevalence, risk factors, and special treatment considerations. Reported prevalence of LAgP as 0.1-0.2% in Caucasians but up to 2.6% in Africans, and GAgP as 0.13% globally. Emphasized ethnic/racial disparities and that treatment plans must account for microbiological variation across populations.
Why it matters for PG exams: Answers epidemiology questions on prevalence by race/ethnicity (African > Asian > Caucasian). The racial/geographic variation is a specific special treatment consideration since microbiology and therefore antibiotic selection may differ.
SUMMARY TABLE for Quick Revision
| # | Author (Year) | Key Point | Importance |
|---|---|---|---|
| 1 | Lang et al. (1999) | Defined LAgP vs GAgP criteria | ⭐⭐⭐⭐⭐ |
| 2 | Tonetti et al. (2018) | 2018 reclassification - abolished "aggressive periodontitis" | ⭐⭐⭐⭐⭐ |
| 3 | Papapanou et al. (2018) | Scientific rationale for 2018 classification | ⭐⭐⭐⭐⭐ |
| 4 | Slots & Genco (1984) | A. actinomycetemcomitans as primary pathogen | ⭐⭐⭐⭐⭐ |
| 5 | Haubek et al. (2008) - Lancet | JP2 clone = 18x risk, causality established | ⭐⭐⭐⭐⭐ |
| 6 | Fine et al. (2007) | Longitudinal colonization → bone loss in LAgP | ⭐⭐⭐⭐ |
| 7 | Van Dyke et al. (1980) | Intrinsic neutrophil chemotaxis defect in LAgP | ⭐⭐⭐⭐⭐ |
| 8 | Shapira et al. (1994) | Monocyte hyper-inflammatory phenotype in AgP | ⭐⭐⭐⭐ |
| 9 | Slots & Rosling (1983) | Tetracycline + SRP for LAgP - original evidence | ⭐⭐⭐⭐⭐ |
| 10 | Guerrero et al. (2005) | Amox+Metro RCT in GAgP - most cited RCT | ⭐⭐⭐⭐⭐ |
| 11 | Herrera et al. (2002) | Systematic review - AgP benefits most from antibiotics | ⭐⭐⭐⭐⭐ |
| 12 | Sgolastra et al. (2012) | Meta-analysis: amox+metro in AgP quantifies benefit | ⭐⭐⭐⭐⭐ |
| 13 | Rabelo et al. (2015) | Bayesian NMA - amox+metro best combination | ⭐⭐⭐⭐ |
| 14 | Kaner et al. (2007) | Timing of antibiotics: concurrent with SRP is better | ⭐⭐⭐⭐ |
| 15 | Mengel et al. (2006) | GTR regeneration feasible in treated GAgP | ⭐⭐⭐⭐ |
| 16 | Mengel et al. (2001) | Implants in GAgP - higher complications but viable | ⭐⭐⭐⭐⭐ |
| 17 | Mengel et al. (2005) | Implants: SPT critical; AgP = peri-implantitis risk | ⭐⭐⭐⭐ |
| 18 | Michalowicz et al. (2000) | Twin study - 50% genetic heritability | ⭐⭐⭐⭐⭐ |
| 19 | Hart & Kornman (1997) | Genetic basis, inheritance patterns of AgP | ⭐⭐⭐⭐ |
| 20 | Kamma & Baehni (2003) | 5-year maintenance: compliance = stability | ⭐⭐⭐⭐ |
| 21 | Albandar (2014) | Global epidemiology, racial disparities | ⭐⭐⭐⭐ |
Exam Focus Tips:
- Questions on antibiotic choice in AgP = always link Guerrero 2005 (GAgP) and Slots/Rosling 1983 (LAgP)
- Questions on classification = must compare 1999 (aggressive periodontitis as entity) vs 2018 (Grade C) frameworks
- Questions on implants = Mengel 2001 is the landmark study; discuss higher peri-implant risk + need for strict maintenance
- Questions on host factors = Van Dyke 1980 (neutrophil defect) + Shapira 1994 (monocyte hyperresponsiveness) = the two immune pillars
- Questions on prognosis/long-term = Kamma & Baehni 2003 + compliance with SPT as the determining factor
- The Haubek Lancet 2008 paper is a standout because it is the only prospective study proving causality for a specific periodontal pathogen - always mention it for questions on microbial risk factors
This is a shared conversation. Sign in to Orris to start your own chat.